Twist Bioscience Partners With AWS to Enable AI-Driven Drug Testing Loop
Twist Bioscience is supplying lab synthesis and testing for AWS’s Amazon Bio Discovery platform, linking AI-designed molecules to rapid experimental validation.
The newest enterprise AI stories, analysis and reporting from Deployed.
Page 37
Twist Bioscience is supplying lab synthesis and testing for AWS’s Amazon Bio Discovery platform, linking AI-designed molecules to rapid experimental validation.
Newfront deployed its AI benefits assistant Benji across Slack and mobile, using generative AI to automate employee queries and reduce HR workload.
SoundHound will acquire LivePerson for $43M, combining voice and messaging AI to build an end-to-end enterprise conversational platform.
"We would really like consumers to recognize Yelp as a place where they can ask questions and get answers, not just that, but also complete the action."
Bayer’s CEO says every new drug starts on computers. The pipeline shows AI shifted discovery upstream, but lab validation still defines outcomes.
AI is embedded across clinical workflows in US healthcare, but federal regulation has not caught up. States are stepping in — with fragmented results.
The companies link in silico prediction with organoid validation to improve translational decision-making in drug discovery.
AI can design and run lab experiments, pointing to autonomous research systems that shift scientific bottlenecks from humans to compute.
HSB data shows widespread AI use, while unclear policy language and new exclusions create gaps in liability coverage.
"Marketers shouldn't have to choose between their organisation's AI tools and the marketing capabilities required to drive impactful outcomes."
The U.S. National Science Foundation has invested more than $1 billion since the late 1960s in research helping computers interpret visual information.
"Our relationship with MaintainX demonstrates how Ignition can serve as the intelligent bridge between industrial data and actionable maintenance workflows."
Managers are not questioning whether AI can work. They are questioning whether it will work in their specific operational context.
AI adoption in healthcare is spreading across drug discovery, clinical trials, and patient billing workflows.
CMS has suspended payments to hundreds of Los Angeles hospice providers, using AI-assisted billing analysis to flag suspected fraud.
Phillips Medisize is embedding sensors into single-use systems to enable real-time data capture as drug development shifts to more complex modalities.
Glidewell Dental outlines an AI-led production system aimed at reducing variability, improving turnaround times, and increasing predictability for dental practices.
At AACR 2026, researchers report a system that identifies social determinants of health from unstructured records with more than 98% accuracy.
Anduril and Edison Chouest Offshore partner to accelerate U.S. autonomous vessel production using existing shipyard capacity and infrastructure.
Walmart's 2025 proxy statement reveals its AI chief out-earned its CEO by $15 million.